OLIG2 Antibody - #DF8004

Fig. 1: Olig2 was overexpressed in lung cancer tissues. a The representative pictures of immunohistochemical staining of Olig2 in paraffin-embedded human lung cancer tissues and non-lung cancer tissues. b Statistical analysis of Olig2 immunohistochemical staining of lung cancer tissues and non-lung cancer tissues, n = 8. c Western blot analysis of Olig2 expression in lung cancer tissues and non-lung cancer tissues, n = 8. d Statistical analysis of Olig2 expression in lung cancer tissues and non-lung cancer tissues, values were normalized to β-actin, n = 8. The data were presented as the mean ± SD, *p 

Fig. 2: Olig2 promoted lung cancer cell stemness. a Average correlations between Olig2 expression and the functional states in glioma. b Representative images and number of tumorspheres with Olig2 knockdown or overexpression in NCI-H820 cells, n = 6. c Representative images and number of NCI-H820 migrated cells with Olig2 knockdown or overexpression, n = 3. d The bioluminescence imaging of lungs with intravenous injection of NCI-H820-luci cells into BAL B/c nude mice for 7 days, n = 5. e Statistical analysis of bioluminescence intensity in lungs, n = 5. f Representative HE staining images of lung and liver metastasis. g The picture of xenograft tumors derived from NCI-H820 cells with intra-tumoral injected Olig2 siRNA or si-NC in lipofectamine 2000. h Xenograft tumor growth curve of Olig2 siRNA or si-NC-transfected group, n = 4. i Xenograft tumor weight of Olig2 siRNA or si-NC-transfected group, n = 4. j Immunohistochemical staining of Olig2 and CD133 of xenograft tumor. k Western bolt analysis of Olig2, CD133, Nanog, and Oct4 expression in xenograft tumors. l Statistical analysis of Olig2, CD133, Nanog, and Oct4 expression in xenograft tumors, values were normalized to β-actin, n = 4. The data were presented as the mean ± SD, *p